Your browser doesn't support javascript.
loading
Clinical efficacy of the optimal biological dose in early-phase trials of anti-cancer targeted therapies.
Corbaux, Pauline; El-Madani, Mévidette; Tod, Michel; Péron, Julien; Maillet, Denis; Lopez, Jonathan; Freyer, Gilles; You, Benoit.
Afiliação
  • Corbaux P; Faculty of Medicine Lyon-Sud, Claude Bernard University Lyon 1, EMR UCBL/HCL 3738, University of Lyon, Lyon, France.
  • El-Madani M; Faculty of Medicine Lyon-Sud, Claude Bernard University Lyon 1, EMR UCBL/HCL 3738, University of Lyon, Lyon, France; Pharmacology Department, National Research Centre, Cairo, Egypt.
  • Tod M; Faculty of Medicine Lyon-Sud, Claude Bernard University Lyon 1, EMR UCBL/HCL 3738, University of Lyon, Lyon, France.
  • Péron J; Faculty of Medicine Lyon-Sud, Claude Bernard University Lyon 1, EMR UCBL/HCL 3738, University of Lyon, Lyon, France; Biometry and Evolutionary Biology Laboratory, Health and Biostatistics Team, CNRS UMR 5558, Claude Bernard University Lyon 1, University of Lyon, Lyon, France.
  • Maillet D; Faculty of Medicine Lyon-Sud, Claude Bernard University Lyon 1, EMR UCBL/HCL 3738, University of Lyon, Lyon, France; Department of Medical Oncology, Cancerology Institute of Hospices Civils de Lyon (IC-HCL), CITOHL, Lyon-Sud Hospital, Lyon, France.
  • Lopez J; Department of Biochemistry and Molecular Biology, Lyon-Sud Hospital, Hospices Civils de Lyon, Lyon, France.
  • Freyer G; Faculty of Medicine Lyon-Sud, Claude Bernard University Lyon 1, EMR UCBL/HCL 3738, University of Lyon, Lyon, France; Department of Medical Oncology, Cancerology Institute of Hospices Civils de Lyon (IC-HCL), CITOHL, Lyon-Sud Hospital, Lyon, France.
  • You B; Faculty of Medicine Lyon-Sud, Claude Bernard University Lyon 1, EMR UCBL/HCL 3738, University of Lyon, Lyon, France; Department of Medical Oncology, Cancerology Institute of Hospices Civils de Lyon (IC-HCL), CITOHL, Lyon-Sud Hospital, Lyon, France. Electronic address: benoit.you@chu-lyon.fr.
Eur J Cancer ; 120: 40-46, 2019 10.
Article em En | MEDLINE | ID: mdl-31479946

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto / Terapia de Alvo Molecular / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto / Terapia de Alvo Molecular / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article